- Home
- NOTV
NOTV
Inotiv Inc.
as 01-17-2025 4:00pm EST
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
| Founded: | 1974 | Country: | United States |
| Employees: | N/A | City: | WEST LAFAYETTE |
| Market Cap: | 126.3M | IPO Year: | 1997 |
| Target Price: | $5.92 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.19 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.23 - $11.42 | Next Earning Date: | 02-05-2025 |
| Revenue: | $490,739,000 | Revenue Growth: | -14.27% |
| Revenue Growth (this year): | 7.14% | Revenue Growth (next year): | 5.73% |
Stock Insider Trading Activity of Inotiv Inc. (NOTV)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Landman David | NOTV | Director | Dec 19 '24 | Buy | $4.25 | 23,529 | $99,998.25 | 176,851 | |
| Beattie John Gregory | NOTV | Chief Operating Officer | Dec 10 '24 | Buy | $4.75 | 30,000 | $142,500.00 | 161,761 | |
| Brown Nigel | NOTV | Director | Dec 10 '24 | Buy | $4.26 | 7,500 | $31,950.00 | 65,537 | |
| Harrington Michael J | NOTV | Director | Dec 6 '24 | Buy | $3.98 | 10,000 | $39,822.00 | 37,500 | |
| Landman David | NOTV | Director | Dec 6 '24 | Buy | $4.14 | 100,000 | $414,000.00 | 176,851 |
Latest Inotiv Inc. News
NOTV Breaking Stock News: Dive into NOTV Ticker-Specific Updates for Smart Investing
MT Newswires
20 days ago
Inotiv Raises Another $3.6 Million From Sale of Additional Shares
GlobeNewswire
20 days ago
Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 Million
MT Newswires
a month ago
Inotiv Raises Net Proceeds of $24 Million From Equity Offering
GlobeNewswire
a month ago
Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $24.0 Million
MT Newswires
a month ago
Inotiv Prices 6 Million Share Offering at $4.25 Per Share
GlobeNewswire
a month ago
Inotiv, Inc. Announces Pricing of Public Offering of 6,000,000 Common Shares
MT Newswires
a month ago
Inotiv Proposes Public Stock Offering
GlobeNewswire
a month ago
Inotiv, Inc. Launches Proposed Public Offering of Common Shares
Compare NOTV vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NOTV Inotiv Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.